+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

From
From
Therapeutic Proteins Global Market Report 2024 - Product Thumbnail Image

Therapeutic Proteins Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Blood and Blood Components Global Market Report 2024 - Product Thumbnail Image

Blood and Blood Components Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Plasma Protein Therapeutics Global Market Report 2024 - Product Thumbnail Image

Plasma Protein Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Blood Preparation Global Market Report 2024 - Product Thumbnail Image

Blood Preparation Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Blood Bank Global Market Report 2024 - Product Thumbnail Image

Blood Bank Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Xenotransplantation Global Market Report 2024 - Product Thumbnail Image

Xenotransplantation Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
AAV vectors in gene therapy - Pipeline Insight, 2024 - Product Thumbnail Image

AAV vectors in gene therapy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 398 Pages
  • Global
From
Anticoagulants Global Market Report 2024 - Product Thumbnail Image

Anticoagulants Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Dermatomyositis - Pipeline Insight, 2024 - Product Thumbnail Image

Dermatomyositis - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 60 Pages
  • Global
From
From
Loading Indicator